## **Core Concept**
Oral anticoagulants, particularly warfarin, are known to have teratogenic effects when administered during pregnancy. The primary concern is the risk of warfarin embryopathy or fetal warfarin syndrome, which includes a range of developmental abnormalities.

## **Why the Correct Answer is Right**
The correct answer, , is associated with warfarin embryopathy. Warfarin acts as a vitamin K antagonist, which is crucial for the gamma-carboxylation and activation of clotting factors in the liver, as well as for the modification of other proteins. During embryogenesis, particularly between the 6th and 12th weeks of gestation, the use of warfarin can disrupt normal development, leading to characteristic features such as nasal hypoplasia, limb abnormalities (e.g., stippling or dysplasia), and other skeletal malformations. This condition is often referred to as "fetal warfarin syndrome."

## **Why Each Wrong Option is Incorrect**
- **Option A:** is incorrect because while oral anticoagulants can increase the risk of bleeding in both mother and fetus, the question specifically asks about effects related to pregnancy and fetal development.
- **Option B:** is incorrect as it does not directly relate to the known teratogenic effects of oral anticoagulants like warfarin.
- **Option D:** is incorrect because it does not accurately describe the primary concern with oral anticoagulant use in pregnancy.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that warfarin is contraindicated during the first and third trimesters of pregnancy due to its teratogenic effects and the risk of fetal bleeding, respectively. Low molecular weight heparin is often used as an alternative for anticoagulation in pregnant women, especially during these critical periods.

## **Correct Answer:** . Warfarin embryopathy